NCT03362944

Brief Summary

Purpose: In this preparatory study, the investigators will demonstrate the feasibility of using a structured MT intervention as a treatment for MDD by measuring stress hormone levels and HRV before and after interventions. Participants: Participants will be healthy controls ages 18 to 34 years old, both male and female, english speakers, with no history or cardiovascular or neurological diseases. Procedures: A passive listening control will be used in conjunction with an active music therapy intervention to assess whether the physiological correlates can be targeted by active music-making. Participants will experience both the control and the intervention in separate sessions for a within participants design. HRV and saliva samples will be recorded pre and post intervention for both sessions. The investigators anticipate that the active MT intervention will produce greater physiological changes (pre intervention to post intervention) than the passive listening control. Model-based estimation of treatment effects and components of variance will inform our choice of the sample size deemed necessary for a subsequent grant-funded MT-MDD clinical trial.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 20, 2017

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

November 29, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 5, 2017

Completed
13 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 18, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 18, 2017

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

June 5, 2019

Completed
Last Updated

June 5, 2019

Status Verified

March 1, 2018

Enrollment Period

28 days

First QC Date

November 29, 2017

Results QC Date

October 29, 2018

Last Update Submit

February 25, 2019

Conditions

Outcome Measures

Primary Outcomes (3)

  • Change From Baseline to Post Intervention High Frequency (HF) and Low Frequency Divided by High Frequency (LF/HF) Power Amplitude

    Five minute heart-rate variability (HRV) recordings will be taken before and after each intervention session through two electrodes placed on the participant's right collarbone and left rib cage. The recordings will be analyzed for HF and LF/HF components, which correspond with sympathetic and parasympathetic autonomic nervous system (ANS) activity.

    Before and after 40-minute intervention

  • Change From Baseline to Post Intervention Cortisol

    Stress hormone levels correspond with hypothalamic-pituitary-adrenal (HPA) axis activity. This will be assessed using saliva swabs.

    Before and after 40-minute intervention

  • Change From Baseline to Post Intervention Alpha-amylase (A-amylase)

    Stress hormone levels correspond with HPA axis activity. This will be assessed using saliva swabs.

    Before and after 40-minute intervention

Secondary Outcomes (3)

  • Active and Passive Music Therapy Post Intervention HF and LF/HF Power Amplitude

    Interventions are administered 1 week apart, post intervention recordings will be taken and compared on a 1 week time frame.

  • Active and Passive Music Therapy Post Intervention Cortisol

    Interventions are administered 1 week apart, post intervention stress hormone levels will be assessed and compared on 1 week time frame.

  • Active and Passive Music Therapy Post Intervention A-amylase

    Interventions are administered 1 week apart, post intervention stress hormone levels will be assessed and compared on 1 week time frame.

Study Arms (2)

Active Music Therapy

EXPERIMENTAL
Behavioral: Active Music Therapy

Passive Music Therapy

EXPERIMENTAL
Behavioral: Passive Music Therapy

Interventions

The intervention consists of a standardized series of Music Therapy tasks, all based at a constant rhythmic pulse.

Active Music Therapy

The intervention consists of a series of recorded listening tracks, matched in style to the active intervention, all based at a constant rhythmic pulse.

Passive Music Therapy

Eligibility Criteria

Age18 Years - 34 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • to 34 years of age
  • Capacity to understand all relevant risks and potential benefits of the study (informed consent)

You may not qualify if:

  • Non-English speaker
  • Cardiovascular disease
  • Neurological diseases
  • On medication for cardiovascular or neurological disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UNC Chapel Hill Medical School Wing C

Chapel Hill, North Carolina, 27599, United States

Location

Related Publications (7)

  • Rafieyan R, Ries R. A description of the use of music therapy in consultation-liaison psychiatry. Psychiatry (Edgmont). 2007 Jan;4(1):47-52.

    PMID: 20805929BACKGROUND
  • Thaut MH, McIntosh GC, Hoemberg V. Neurobiological foundations of neurologic music therapy: rhythmic entrainment and the motor system. Front Psychol. 2015 Feb 18;5:1185. doi: 10.3389/fpsyg.2014.01185. eCollection 2014.

    PMID: 25774137BACKGROUND
  • Ellis RJ, Thayer JF. Music and Autonomic Nervous System (Dys)function. Music Percept. 2010 Apr;27(4):317-326. doi: 10.1525/mp.2010.27.4.317.

    PMID: 21197136BACKGROUND
  • Linnemann A, Ditzen B, Strahler J, Doerr JM, Nater UM. Music listening as a means of stress reduction in daily life. Psychoneuroendocrinology. 2015 Oct;60:82-90. doi: 10.1016/j.psyneuen.2015.06.008. Epub 2015 Jun 21.

    PMID: 26142566BACKGROUND
  • Dean J, Keshavan M. The neurobiology of depression: An integrated view. Asian J Psychiatr. 2017 Jun;27:101-111. doi: 10.1016/j.ajp.2017.01.025. Epub 2017 Jan 29.

    PMID: 28558878BACKGROUND
  • Mikutta CA, Schwab S, Niederhauser S, Wuermle O, Strik W, Altorfer A. Music, perceived arousal, and intensity: psychophysiological reactions to Chopin's "Tristesse". Psychophysiology. 2013 Sep;50(9):909-19. doi: 10.1111/psyp.12071. Epub 2013 Jun 14.

    PMID: 23763714BACKGROUND
  • Rajendra Acharya U, Paul Joseph K, Kannathal N, Lim CM, Suri JS. Heart rate variability: a review. Med Biol Eng Comput. 2006 Dec;44(12):1031-51. doi: 10.1007/s11517-006-0119-0. Epub 2006 Nov 17.

    PMID: 17111118BACKGROUND

Related Links

Results Point of Contact

Title
Trevor McPherson
Organization
Frohlich Lab - University of North Carolina at Chapel HIll

Study Officials

  • Flavio Frohlich, PhD

    UNC Chapel Hill

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 29, 2017

First Posted

December 5, 2017

Study Start

November 20, 2017

Primary Completion

December 18, 2017

Study Completion

December 18, 2017

Last Updated

June 5, 2019

Results First Posted

June 5, 2019

Record last verified: 2018-03

Locations